2 completed, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow MK 0873: new trials by email Literature Review of MK 0873 trials Research Report on MK 0873
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022) MK-0873 2% Cream, MK-0873 vehicle (placebo) Cream, Calcitriol Cream - Psoriasis, Plaque Psoriasis | Phase 1 | Completed | Merck Sharp & Dohme LLC | 24 | 2010-11-01 | 2019-02-08 |
| A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED) MK-0873, Comparator: Placebo - Rheumatoid Arthritis | Phase 2 | Completed | Merck Sharp & Dohme LLC | 106 | 2005-01-01 | 2015-07-30 |
| An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005) MK-0873 2.5 mg, MK-0873 1.25 mg, MK-0873 0.75 mg - Lung Diseases, Pulmonary Disease, Chronic Obstructive | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 604 | 2004-06-01 | 2018-10-12 |
Arthritis, Rheumatoid (1) · Lung Diseases (1) · Psoriasis (1) · Pulmonary Disease, Chronic Obstructive (1)
United States (1)